Greenberg Traurig Hosts Boston Healthcare Drinks and Discussion on China Biopharma Industry

Share Article

On Wednesday, Dec. 12, Greenberg Traurig, LLP’s Boston office sponsored and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China Managing Partner of L.E.K. Chen shared her insights on “Biopharma Business Opportunities Arising from China.”

On Wednesday, Dec. 12, Greenberg Traurig, LLP’s Boston office sponsored and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China Managing Partner of L.E.K. Chen shared her insights on “Biopharma Business Opportunities Arising from China.”

The discussion was moderated by patent attorney David J. Dykeman, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group and co-chair of the firm’s Intellectual Property (IP) Group in Boston, and by Dr. Fang Xie, patent attorney and Boston office shareholder.

Prior to the program, Greenberg Traurig CEO Brian L. Duffy and Scott J. Bornstein, co-chair of the firm's Global Intellectual Property & Technology Practice and co-chair of the firm's Global Patent Litigation Group, welcomed guests, highlighting their recent trip to China and the firm's strong commitment to China and Asia in general. Greenberg Traurig has offices in Shanghai, China, and in Japan and Korea.

Since 2016, Greenberg Traurig has sponsored and hosted the Healthcare Drinks Boston Chapter in the firm’s Boston office. Healthcare Drinks provides a platform for management in the health care industry to meet, exchange ideas and socialize in a casual yet professional, educational and supportive atmosphere.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from startups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing. As part of the group, the Biotechnology and Pharmaceutical Industry Group focuses on advising clients in the biotechnology and pharmaceutical sectors.

About Greenberg Traurig’s Boston Office: Established in 1999, Greenberg Traurig’s Boston office is home to approximately 70 attorneys practicing in the areas of bankruptcy, corporate, emerging technology, energy, gaming, intellectual property, labor and employment, life sciences and medical technology, litigation, public finance, and real estate. An important contributor to the firm's international platform, the Boston office includes a team of nationally recognized attorneys with both public and private sector experience. The team offers clients the value of decades of legal experience and hands-on knowledge of the local business community, supported by the firm's vast network of global resources.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2018 Am Law Global 100. Web: http://www.gtlaw.com; Twitter: @GT_Law.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo-Martinez
@GT_Law
Follow >
Visit website